Neuropathology of Dementing Disorders

August 1999
Journal of Neurology, Neurosurgery & Psychiatry;Aug1999, p259
Academic Journal
No abstract available.


Related Articles

  • The oldest old Creutzfeldt-Jakob disease case. Buganza, M.; Ferrari, S.; Cecchini, M. E.; Orrico, D.; Monaco, S.; Zanusso, G. // Journal of Neurology, Neurosurgery & Psychiatry;Oct2009, Vol. 80 Issue 10, p23 

    Sporadic Creutzfeldt-Jakob Disease (sCJD) is a rapidly progressive neurodegenerative disorder usually affecting people between 60 and 70 years old, with only anecdotal cases presenting at 90 years or older. The clinical phenotype of sCJD is highly variable. Diagnosis of sCJD should be considered...

  • Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. Reisberg, B.; Franssen, Emile H.; Hasan, Syed Mahmood; Monteiro, Isabel; Boksay, Istvan; Souren, Liduin E. M.; Kenowsky, Sunnie; Auer, Stefanie R.; Elahi, Shahid; Kluger, Alan // European Archives of Psychiatry & Clinical Neuroscience;1999 Supplement 3, Vol. 249, pS28 

    Abstract Data from clinical, electrophysiologic, neurophysiologic, neuroimaging and neuropathologic sources indicates that the progression of brain aging and Alzheimer's disease (AD) deterioration proceeds inversely to human ontogenic acquisition patterns. A word for this process of degenerative...

  • Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? Jellinger, Kurt // Acta Neuropathologica;Feb2009, Vol. 117 Issue 2, p101 

    There are several consensus criteria for both the clinical and neuropathological diagnosis of different types of dementias. The clinical diagnostic accuracy using revised research criteria and newly developed biomarkers (MRI, PET, CSF analysis, genetic markers) ranges from 65 to 96% (for...

  • Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Dickson, Dennis W. // Acta Neuropathologica;Jan2005, Vol. 109 Issue 1, p14 

    Modern neuropathologic methods and molecular biology have lead to increased understanding of neurodegenerative disorders and biologically based classifications of these disorders. The purpose of this review is to discuss neuropathologic methods that are useful in the characterization of...

  • Mild cognitive impairment: pathology and mechanisms. Mufson, Elliott; Binder, Lester; Counts, Scott; DeKosky, Steven; deToledo-Morrell, Leyla; Ginsberg, Stephen; Ikonomovic, Milos; Perez, Sylvia; Scheff, Stephen // Acta Neuropathologica;Jan2012, Vol. 123 Issue 1, p13 

    Mild cognitive impairment (MCI) is rapidly becoming one of the most common clinical manifestations affecting the elderly. The pathologic and molecular substrate of people diagnosed with MCI is not well established. Since MCI is a human specific disorder and neither the clinical nor the...

  • The Nun Study: Risk Factors for Pathology and Clinical-Pathologic Correlations. A. Mortimer, James // Current Alzheimer Research;Jul2012, Vol. 9 Issue 6, p621 

    The Nun Study was the first cohort study to enroll and follow a large, well-defined population that included demented and non-demented participants, all of whom agreed to donate their brains for research. The inclusion of systematic neuropathologic analysis in this study has resulted in a...

  • Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging. Maarouf, Chera L.; Daugs, Ian D.; Kokjohn, Tyler A.; Walker, Douglas G.; Hunter, Jesse M.; Kruchowsky, Jane C.; Woltjer, Randy; Kaye, Jeffrey; Castaño, Eduardo M.; Sabbagh, Marwan N.; Beach, Thomas G.; Roher, Alex E. // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades....

  • The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies. Wennström, Malin; Surova, Yulia; Hall, Sara; Nilsson, Christer; Minthon, Lennart; Hansson, Oskar; Nielsen, Henrietta M. // PLoS ONE;8/13/2015, Vol. 10 Issue 8, p1 

    A major difference in the revised diagnostic criteria for Alzheimer’s disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due to AD neuropathological processes. However, AD-specific fluid biomarkers which...

  • Neuroanatomical Studies of Major Affective Disorders: A Review and Suggestions for Further Research. Jeste, Dilip V.; Lohr, James B.; Goodwin, Frederick K. // British Journal of Psychiatry;Oct88, Vol. 153, p444 

    Interest in the long-neglected neuropathology of major affective disorders has recently been rekindled, partly because of the emergence of brain-imaging techniques. We review the literature suggesting that attention be given to the neuroanatomy and neuropathology of primary and secondary...

  • Acute decompensation in dementia: Recognition and management. Patterson, C.; LeClair, J. K. // Geriatrics;Aug1989, Vol. 44 Issue 8, p20 

    Dementing illnesses are chronic disorders causing global impairment of intellectual function. The most common cause is Alzheimer's disease, and this, together with most other forms of dementing illness, is relentlessly progressive. Frequently, however, there is an abrupt deterioration in...


Read the Article


Sign out of this library

Other Topics